Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.
Cakar
Mustafa
M
Aksoy
Sercan
S
Kilickap
Saadettin
S
Harputluoglu
Hakan
H
Erman
Mustafa
M
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary*; D005500:Follow-Up Studies; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use*; D008207:Lymphatic Metastasis / Q000175:diagnosis / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008527:Medulloblastoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D011344:Procarbazine / Q000627:therapeutic use*; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D011344:Procarbazine; D014750:Vincristine; D008130:Lomustine